Why Therapy Doesn’t Work for Everyone. Why Talking About It Might.
The most exciting phrase to hear in science, the one that heralds new discoveries, is not ‘Eureka!’ but ‘Hmmm. That's funny...’ – Isaac Asimov
Thursday, December 01, 2005
Breast Cancer Drug and Bipolar Disorder
The anti-cancer drug tamoxifen is currently being studied on people with bipolar disorder. The drug appears to affect protein kinase C, or PKC, which researchers think might be involved in bipolar disorder. Ultimately, if research findings are positive, researchers hope to develop a new class of quick-acting drugs. (See also my article in BP Magazine.
The purpose of this blog is to alert readers about novel research taking place in the field of neurology, specifically mental health disorders, to give hope to those who suffer and to promote the work of those scientists who are unbridled by conventional wisdom.
If you Google me (Stacie Z. Berg) you may see that I am an award-winning medical/science journalist and you can certainly see that I write on a variety of subjects, from personal finance to computer technology and information security to medicine. Medicine, however, is my primary field of interest. I have successfully pitched editors on probably hundreds of stories over the years. And over the years, I couldn't help but notice the ones that kept getting rejected were those that took a different approach to covering brain disorders that affect thoughts and emotions (better known as "psychiatric" disorders - but the mind is in the brain). Virtually all the editors seemed to want a repetition of what's already been covered, namely treatment with selective serotonin reuptake inhibitors (SSRIs), exposure therapy, and talk therapy, as I could see by what little coverage there was. One exception was this article (Insight LINK). So, I decided to post information here rather than have them collect dust on the cutting room floor.
0 Comments:
Post a Comment
<< Home